Cefotaxime sodium and Atorvastatin calcium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefotaxime sodium (cefotaxime sodium) and Atorvastatin calcium (atorvastatin calcium). Common drug interactions include renal failure among females and kidney transplant rejection among males.

The phase IV clinical study analyzes what interactions people have when they take Cefotaxime sodium and Atorvastatin calcium. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Cefotaxime sodium?

Cefotaxime sodium has active ingredients of cefotaxime sodium. eHealthMe is studying from 2,549 Cefotaxime sodium users. Check the latest studies of Cefotaxime sodium.

What is Atorvastatin calcium?

Atorvastatin calcium has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 77,309 Atorvastatin calcium users. Check the latest studies of Atorvastatin calcium.



On Jul, 18, 2026

24 people who take Cefotaxime sodium and Atorvastatin calcium together, and have interactions are studied.

Cefotaxime sodium and Atorvastatin calcium drug interactions.

What are the common drug interactions of Cefotaxime Sodium and Atorvastatin Calcium, by gender? *:

female:

  1. Renal failure (kidney dysfunction)
  2. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  3. White blood cell count decreased
  4. White blood cell count increased
  5. Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Pneumonia viral
  8. Alopecia (absence of hair from areas of the body)
  9. Blood creatinine increased
  10. Contusion (a type of hematoma of tissue in which capillaries)

male:

  1. Kidney transplant rejection
  2. Purpura (purplish discoloration of the skin)
  3. Skin exfoliation (removal of the oldest dead skin cells)
  4. Acute respiratory failure
  5. Agitation (state of anxiety or nervous excitement)
  6. Anaemia (lack of blood)
  7. Arthralgia (joint pain)
  8. Aspartate aminotransferase increased
  9. Atelectasis (partial or complete collapse of the lung)
  10. Back pain

What are the common drug interactions of Cefotaxime Sodium and Atorvastatin Calcium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cardiac failure
  2. Complications of transplanted kidney
  3. Cough
  4. Diarrhoea
  5. Oliguria (not enough urine)
  6. Anaemia (lack of blood)
  7. Arthralgia (joint pain)
  8. Back pain
  9. Bk virus infection
  10. Blood glucose increased

40-49:

  1. Kidney transplant rejection
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Drug ineffective

50-59:

  1. Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
  2. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  3. Pneumonia viral
  4. Acute respiratory failure
  5. Atelectasis (partial or complete collapse of the lung)
  6. Bacterial test positive
  7. Blood pressure decreased
  8. Cardiac arrest
  9. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  10. Cardiomegaly (increased size of heart than normal)

60+:

  1. Purpura (purplish discoloration of the skin)
  2. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  3. Blood albumin decreased
  4. Blood alkaline phosphatase increased
  5. Blood calcium decreased
  6. Blood lactate dehydrogenase increased
  7. Blood potassium increased
  8. Blood pressure systolic increased
  9. Blood sodium decreased
  10. Capillary disorder (capillary disease)

What are the existing conditions these people have? *

  1. High Blood Pressure: 8 people, 33.33%
  2. Dyslipidaemia (abnormal amount of lipids): 6 people, 25.00%
  3. Pneumonia: 4 people, 16.67%
  4. Cardioversion: 3 people, 12.50%
  5. Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 8.33%
  6. Pneumonia Bacterial (pneumonia associated with bacterial infection): 2 people, 8.33%
  7. Lung Disorder (lung disease): 2 people, 8.33%
  8. Lung Cancer Metastatic (lung cancer spreads to other parts): 2 people, 8.33%
  9. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 8.33%
  10. Gout (uric acid crystals building up in the body): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cefotaxime sodium and Atorvastatin calcium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefotaxime sodium and Atorvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefotaxime sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Atorvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefotaxime sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atorvastatin calcium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cefotaxime sodium and atorvastatin calcium (the active ingredients of Cefotaxime sodium and Atorvastatin calcium, respectively), and Cefotaxime sodium and Atorvastatin calcium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: